WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Molecular Matrix, Inc. (MMI), a leader in regenerative medicine polymer technology, is proud to announce the full launch of its Osteo-P® Synthetic Bone Graft ...
Novavax (NVAX) has become a focus for investors after signing a license agreement that allows Pfizer to use its Matrix-M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results